Furthermore, to define the best strategy of therapeutic sequence, a better knowledge of the biological and clinical aspects of cancers harboring ALK aberrations is highly recommended, thus offering patients the strongest and longest response with the best quality of life. The gene discussed is ALK; the disease is cancer.